sarcosine has been researched along with paclitaxel in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chang, JY; Huang, HM; Lee, WH; Liou, JP; Liu, HE | 1 |
| Chen, YJ; Huang, HM; Huang, YW; Lee, YL; Liou, JP; Liu, HE; Wang, CC | 1 |
2 other study(ies) available for sarcosine and paclitaxel
| Article | Year |
|---|---|
MPT0B169, a new tubulin inhibitor, inhibits cell growth and induces G2/M arrest in nonresistant and paclitaxel-resistant cancer cells.
Topics: Antineoplastic Agents, Phytogenic; Cell Line, Tumor; Cell Proliferation; Drug Resistance, Neoplasm; G2 Phase; Humans; Neoplasms; Paclitaxel; Sarcosine; Sulfonamides; Tubulin; Tubulin Modulators | 2013 |
MPT0B169, a novel tubulin inhibitor, induces apoptosis in taxol-resistant acute myeloid leukemia cells through mitochondrial dysfunction and Mcl-1 downregulation.
Topics: Apoptosis; Caspase 3; Caspase 9; Cell Line, Tumor; Cytochromes c; Drug Resistance, Neoplasm; Gene Expression Regulation, Leukemic; Gene Knockdown Techniques; HL-60 Cells; Humans; Leukemia, Myeloid, Acute; Membrane Potential, Mitochondrial; Mitochondria; Myeloid Cell Leukemia Sequence 1 Protein; Paclitaxel; Sarcosine; Sulfonamides; Tubulin Modulators | 2016 |